Polarean Imaging plc

Equities

POLX

GB00BF3DT583

Advanced Medical Equipment & Technology

Market Closed - London S.E. Other stock markets 16:35:06 23/05/2024 BST			5-day change	1st Jan Change
1.35 ^GBX	+10,814.89%		-64.94%	-78.40%

05-22	Powerhouse resolves claim; PCI-PAL wins court case	AN
05-22	Polarean Imaging Seeks $10 Million from Share Sale	MT

Polarean hires new CEO as Richard Hullihen retires

June 21, 2023 at 11:02 am

Polarean Imaging PLC - London-based medical imaging technology company - Hires Brainsway Chief Executive Officer Christopher von Jako as new CEO. Says he will be succeeding CEO Richard Hullihen, who will be retiring after seven years in the role, and will also be stepping down as director of the company immediately.

Polarean Chair Kenneth West says: "On behalf of the board, I'd like to thank Richard for his contribution to the business, and we wish him well in his retirement.

"I would also like to welcome Chris to Polarean. His extensive experience in leading commercial-stage MedTech companies, and his training and expertise in radiology, will be an excellent fit for Polarean as we continue our dual strategy of achieving commercial sales of Xenoview and establishing strategic industry collaborations to accelerate growth in the US and internationally."

Current stock price: 26.99 pence, down 6.1% on Wednesday

12-month change: down 45%

By Sabrina Penty, Alliance News reporter

Comments and questions to newsroom@alliancenews.com

Stocks mentioned in the article

	Add to a list Add to a list 0 selected To use this feature you must be a member Log in Sign up	Price	Change	5d. change	Capi.
	BRAINSWAY LTD.	1,007 ILa	+1.23%	+0.70%	90.15M
	POLAREAN IMAGING PLC	1.35 GBX	+10,814.89%	-64.94%	3.99M

Latest news about Polarean Imaging plc

Powerhouse resolves claim; PCI-PAL wins court case	05-22	AN
Polarean Imaging Seeks $10 Million from Share Sale	05-22	MT
Polarean Imaging to raise USD10 million via placing and subscription	05-21	AN
Polarean Imaging Wins Order for Xenon MRI System in US	05-10	MT
FTSE 100 hits record high on BoE vote, UK GDP	05-10	AN
Polarean shares soar on University of Alabama deal for Xenon MRI	05-10	AN
AIM WINNERS & LOSERS: Polarean wins deal; Genedrive completes placing	05-10	AN
Polarean Imaging plc Receives Second De Novo Order for A New Xenon MRI System from the University of Alabama At Birmingham Hospital	05-10	CI
Polarean Imaging wins order for new polariser	05-03	AN
Polarean Imaging Wins Order for Hyperpolarization System in US	05-03	MT
Polarean Imaging plc Receives Order for Upgraded Hyperpolariser	05-03	CI
Nexteq confident of meeting full-year expectations	04-16	AN
Polarean Imaging Secures New Patent for Hyperpolarized Imaging Platform	04-16	MT
Polarean Imaging shares sink after announcing a costly strategic plan	02-29	AN
Polarean Imaging strategic parter raises stake to above 10%	01-15	AN
Nukem Isotopes Ups Polarean Imaging Stake	01-15	MT
Polarean shares jump on Xenoview polariser order	12-07	AN
AIM WINNERS & LOSERS: Smart Metering accepts offer; order for Polarean	12-07	AN
Polarean Imaging Plc Receives First De Novo Order for A New XENOVIEWtm Polariser	12-07	CI
Polarean Imaging Teams up with Vida Diagnostics on Magnetic Resonance Imaging Platform	08/09/23	MT
Polarean Imaging partners with Vida Diagnostics on MRI solutions	08/09/23	AN
Polarean Imaging plc Partnership with VIDA Diagnostics, Inc. to Streamline Adoption of Advanced MRI of the Lungs	08/09/23	CI
FTSE 100 Closes Up 0.21% on Pound Weakness	07/09/23	DJ
UK Inflation Expectations Fall, Boosting Prospects for BOE Rate Pause	07/09/23	DJ
Polarean withdraws commercial targets on revenue drop	07/09/23	AN

Chart Polarean Imaging plc

Duration

Period

More charts

Company Profile

Polarean Imaging PLC is a medical-imaging technology company, with an investigational drug-device combination product for magnetic resonance imaging (MRI). The Company and its subsidiary company operate as investigational drug-device combination companies operating in the high-resolution medical imaging research space. The Company develops equipment that enables existing MRI systems to achieve an improved level of pulmonary functional imaging and specializes in the use of hyperpolarized xenon gas (129Xe) as an imaging agent to visualize ventilation. 129Xe gas is being studied for visualization of gas exchange regionally in the smallest airways of the lungs, across the alveolar tissue membrane, and into the pulmonary bloodstream. The Companyâs technology provides an investigational diagnostic approach, offering a non-invasive and radiation-free functional imaging platform. It operates in Canada, Germany, United Kingdom and United States. The Companyâs subsidiary is Polarean, Inc.

Sector

Advanced Medical Equipment & Technology

Calendar

11/06/2024 - Q4 2023 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Chiffre d''affaires - Rate of surprise

Company calendar

Sector Medical Diagnostic & Testing Equipment

	1st Jan change	Capi.
POLAREAN IMAGING PLC	-78.40%	3.99M
SARTORIUS AG	-21.31%	17.75B
QUIDELORTHO CORPORATION	-42.58%	2.85B
INNER MONGOLIA FURUI MEDICAL SCIENCE CO., LTD.	+21.31%	1.92B
SHANGHAI MICROPORT EP MEDTECH CO., LTD.	-7.25%	1.58B
SHANGHAI AOHUA PHOTOELECTRICITY ENDOSCOPE CO., LTD.	-18.78%	952M
CONTEC MEDICAL SYSTEMS CO.,LTD	-22.39%	888M
REVENIO GROUP OYJ	+4.64%	828M
VAREX IMAGING CORPORATION	-26.68%	611M
CELLAVISION AB	+19.10%	591M

Medical Diagnostic & Testing Equipment